![Annual and Sustainability Report 2023.png](/sites/default/files/styles/call_to_action_desktop_1x/public/media/image/2024-04/Annual%20and%20Sustainability%20Report%202023.png?h=a80c1120&itok=GXHQ9_vc)
Annual and Sustainability Report 2023
On April 11, 2024 CellaVision published its Annual and Sustainability Report for 2023.
Key figures
Questions? We're here to help
![Brown hair woman having a conversation.](/sites/default/files/styles/avatar_desktop_1x/public/media/image/2022-03/MicrosoftTeams-image%20%283%29.png?itok=o8NVSnFr)
![Two people having a conversation with a lab worker in the background](/sites/default/files/styles/call_to_action_desktop_1x/public/media/image/2022-04/CellaVision_in_brief.png?h=ac778ff2&itok=P8kZAgmd)
CellaVision in brief
About 20 years ago, CellaVision introduced automation and digital imaging to cell morphology, thereby creating what today is known as Digital Cell Morphology. Today, we offer a family of products that form a unique and flexible automation concept that helps Laboratory Managers address the key challenges associated with morphological cell analysis.
Explore more
The share
The CellaVision share has been listed on the NASDAQ Stockholm, Mid Cap since 2018. Learn more about the CellaVision share here.
![The Share](/sites/default/files/styles/learn_more_desktop_1x/public/media/image/2022-04/The-share.png?h=ac778ff2&itok=-On4wQEE)
Corporate governance
CellaVision is committed to the corporate governance principles to promote business competitiveness and investor confidence.
![A long meeting table with chairs and a screen on a wall.](/sites/default/files/styles/learn_more_desktop_1x/public/media/image/2022-04/corp_govern.png?h=d1fa73b1&itok=NyZ8rgtM)
About us
We help hematology laboratories automate and simplify the process of performing blood and body fluid differentials.
![About us](/sites/default/files/styles/learn_more_desktop_1x/public/media/image/2022-04/abous_us_.png?h=ac778ff2&itok=VBAV3a2D)